Hikma Pharmaceuticals PLC.

In News

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines - PR Newswire

PR Newswire - Jun 28, 2025

Hikma Pharmaceuticals (OTCMKTS:HKMPF) Shares Gap Up - Time to Buy? - MarketBeat

MarketBeat - Feb 12, 2026

OneSource-Hikma partnership secures approval to commercialise generic version of Ozempic® in Saudi Arabia - BioSpectrum Asia

BioSpectrum Asia - Feb 11, 2026

Brookfield confirms it will not make offer for Hikma Pharmaceuticals - Investing.com

Investing.com - Feb 04, 2026

Hikma Pharma tumbles as injectables guidance cut - Proactive financial news

Proactive financial news - Nov 06, 2025

OneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout - Medical Dialogues

Medical Dialogues - Feb 12, 2026

OneSource gets Saudi nod for Ozempic generic, partner Hikma will commercialise - Moneycontrol

Moneycontrol - Feb 11, 2026

White & Case advises joint lead managers on Hikma Pharmaceuticals’ US$500 million bond issuance - White & Case LLP

White & Case LLP - Jul 23, 2025

Hikma Pharmaceuticals PLC (LON:HIK) is favoured by institutional owners who hold 59% of the company - Yahoo Finance

Yahoo Finance - Sep 19, 2025

Hikma, IFC sign $250mn deal, marking a 40-year partnership driving access to quality medicines in the MENA region - International Finance Corporation (IFC)

International Finance Corporation (IFC) - Jul 15, 2025

Hikma Pharmaceuticals PLC (LON:HIK) is largely controlled by institutional shareholders who own 59% of the company - simplywall.st

simplywall.st - Feb 06, 2026

Hikma chief steps down after profit forecast cuts and factory delays - Financial Times

Financial Times - Dec 15, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment